Connection

Donald Castell to Hydrogen-Ion Concentration

This is a "connection" page, showing publications Donald Castell has written about Hydrogen-Ion Concentration.
Connection Strength

5.189
  1. The limitations of pH monitoring for detecting gastroesophageal reflux. Clin Gastroenterol Hepatol. 2006 Sep; 4(9):1184; author reply 1185.
    View in: PubMed
    Score: 0.243
  2. Postprandial stomach contents have multiple acid layers. J Clin Gastroenterol. 2006 Aug; 40(7):612-7.
    View in: PubMed
    Score: 0.241
  3. Reflux monitoring: role of combined multichannel intraluminal impedance and pH. Gastrointest Endosc Clin N Am. 2005 Apr; 15(2):361-71.
    View in: PubMed
    Score: 0.220
  4. Twenty-four hour ambulatory simultaneous impedance and pH monitoring: a multicenter report of normal values from 60 healthy volunteers. Am J Gastroenterol. 2004 Jun; 99(6):1037-43.
    View in: PubMed
    Score: 0.208
  5. Dose-dependent control of intragastric pH by pantoprazole, 10, 20 or 40 mg, in healthy volunteers. Aliment Pharmacol Ther. 2002 Apr; 16(4):829-36.
    View in: PubMed
    Score: 0.179
  6. Sporadic Fundic Gland Polyps and Gastric Acid Suppression Level. Am J Med Sci. 2017 12; 354(6):561-564.
    View in: PubMed
    Score: 0.129
  7. Exclusion of the meal period improves the clinical reliability of esophageal pH monitoring. J Clin Gastroenterol. 1997 Jul; 25(1):314-6.
    View in: PubMed
    Score: 0.129
  8. Twice-daily proton pump inhibitor therapy does not decrease the frequency of reflux episodes during nocturnal recumbency in patients with refractory GERD: analysis of 200 patients using multichannel intraluminal impedance-pH testing. Dis Esophagus. 2012 Nov-Dec; 25(8):682-6.
    View in: PubMed
    Score: 0.088
  9. Extraesophageal gastroesophageal reflux disease (GERD) symptoms are not more frequently associated with proximal esophageal reflux than typical GERD symptoms. Dis Esophagus. 2012 Nov-Dec; 25(8):678-81.
    View in: PubMed
    Score: 0.088
  10. Swallow evaluation during multichannel intraluminal impedance and pH: an alternate method to assess esophageal transit. J Clin Gastroenterol. 2011 Nov-Dec; 45(10):862-6.
    View in: PubMed
    Score: 0.087
  11. Comparison of reflux frequency during prolonged multichannel intraluminal impedance and pH monitoring on and off acid suppression therapy. J Clin Gastroenterol. 2009 Oct; 43(9):816-20.
    View in: PubMed
    Score: 0.075
  12. Addition of a H2 receptor antagonist to PPI improves acid control and decreases nocturnal acid breakthrough. J Clin Gastroenterol. 2008 Jul; 42(6):676-9.
    View in: PubMed
    Score: 0.069
  13. Reflux testing in the 21st century: is there a role for pH only? Clin Gastroenterol Hepatol. 2008 Aug; 6(8):840-1.
    View in: PubMed
    Score: 0.069
  14. Characteristics of symptomatic reflux episodes on Acid suppressive therapy. Am J Gastroenterol. 2008 May; 103(5):1090-6.
    View in: PubMed
    Score: 0.068
  15. An analysis of persistent symptoms in acid-suppressed patients undergoing impedance-pH monitoring. Clin Gastroenterol Hepatol. 2008 May; 6(5):521-4.
    View in: PubMed
    Score: 0.068
  16. Combined multichannel intraluminal impedance-pH monitoring to select patients with persistent gastro-oesophageal reflux for laparoscopic Nissen fundoplication. Br J Surg. 2006 Dec; 93(12):1483-7.
    View in: PubMed
    Score: 0.062
  17. Review article: complete gastro-oesophageal reflux monitoring - combined pH and impedance. Aliment Pharmacol Ther. 2006 Sep; 24 Suppl 2:27-37.
    View in: PubMed
    Score: 0.061
  18. Nonacid reflux in patients with chronic cough on acid-suppressive therapy. Chest. 2006 Aug; 130(2):386-91.
    View in: PubMed
    Score: 0.060
  19. Comparison between the combined analysis and the DeMeester Score to predict response to PPI therapy. J Clin Gastroenterol. 2006 Aug; 40(7):602-5.
    View in: PubMed
    Score: 0.060
  20. Effects of a 5-HT(4) receptor agonist on oesophageal function and gastro-oesophageal reflux: studies using combined impedance-manometry and combined impedance-pH. Aliment Pharmacol Ther. 2006 Jul 01; 24(1):155-62.
    View in: PubMed
    Score: 0.060
  21. Clinical relevance of the nutcracker esophagus: suggested revision of criteria for diagnosis. J Clin Gastroenterol. 2006 Jul; 40(6):504-9.
    View in: PubMed
    Score: 0.060
  22. Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoring. Gut. 2006 Oct; 55(10):1398-402.
    View in: PubMed
    Score: 0.059
  23. Esophageal pH monitoring: wireless does not mean worry less. J Clin Gastroenterol. 2006 Feb; 40(2):91-2.
    View in: PubMed
    Score: 0.058
  24. Ingestion of acidic foods mimics gastroesophageal reflux during pH monitoring. Dig Dis Sci. 2005 Oct; 50(10):1916-20.
    View in: PubMed
    Score: 0.057
  25. Nighttime reflux is primarily an early event. J Clin Gastroenterol. 2005 Aug; 39(7):579-83.
    View in: PubMed
    Score: 0.056
  26. Esophageal pH monitoring on PPI therapy: removing the blinders. Am J Gastroenterol. 2005 Aug; 100(8):1893-4; author reply 1894.
    View in: PubMed
    Score: 0.056
  27. The role of proximal pH monitoring. Am J Gastroenterol. 2005 Jul; 100(7):1621-2.
    View in: PubMed
    Score: 0.056
  28. Comparison of the effects of immediate-release omeprazole powder for oral suspension and pantoprazole delayed-release tablets on nocturnal acid breakthrough in patients with symptomatic gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2005 Jun 15; 21(12):1467-74.
    View in: PubMed
    Score: 0.056
  29. Fundoplication eliminates chronic cough due to non-acid reflux identified by impedance pH monitoring. Thorax. 2005 Jun; 60(6):521-3.
    View in: PubMed
    Score: 0.056
  30. Non-acid gastroesophageal reflux: documenting its relationship to symptoms using multichannel intraluminal impedance (MII). Trans Am Clin Climatol Assoc. 2005; 116:321-33; discussion 333-4.
    View in: PubMed
    Score: 0.054
  31. The influence of rapid food intake on postprandial reflux: studies in healthy volunteers. Am J Gastroenterol. 2004 Sep; 99(9):1645-51.
    View in: PubMed
    Score: 0.053
  32. Nocturnal acid breakthrough: pH, drugs and bugs. Eur J Gastroenterol Hepatol. 2004 May; 16(5):441-3.
    View in: PubMed
    Score: 0.052
  33. Use of multichannel intraluminal impedance to document proximal esophageal and pharyngeal nonacidic reflux episodes. Am J Med. 2003 Aug 18; 115 Suppl 3A:119S-123S.
    View in: PubMed
    Score: 0.049
  34. Ambulatory intraesophageal pH monitoring: the reigning standard for reflux monitoring. J Clin Gastroenterol. 2003 Jul; 37(1):3-4.
    View in: PubMed
    Score: 0.049
  35. Baclofen decreases acid and non-acid post-prandial gastro-oesophageal reflux measured by combined multichannel intraluminal impedance and pH. Aliment Pharmacol Ther. 2003 Jan; 17(2):243-51.
    View in: PubMed
    Score: 0.047
  36. Over-the-counter H(2)-receptor antagonists do not compromise intragastric pH control with proton pump inhibitors. Aliment Pharmacol Ther. 2002 Mar; 16(3):473-7.
    View in: PubMed
    Score: 0.044
  37. Combined multichannel intraluminal impedance and pH-metry: an evolving technique to measure type and proximal extent of gastroesophageal reflux. Am J Med. 2001 Dec 03; 111 Suppl 8A:157S-159S.
    View in: PubMed
    Score: 0.044
  38. Bedtime H2 blockers improve nocturnal gastric acid control in GERD patients on proton pump inhibitors. Aliment Pharmacol Ther. 2001 Sep; 15(9):1351-6.
    View in: PubMed
    Score: 0.043
  39. Control of intragastric pH with omeprazole 20 mg, omeprazole 40 mg and lansoprazole 30 mg. Aliment Pharmacol Ther. 2001 May; 15(5):647-52.
    View in: PubMed
    Score: 0.042
  40. Maximal acid reflux control for Barrett's oesophagus: feasible and effective. Aliment Pharmacol Ther. 2001 Apr; 15(4):519-24.
    View in: PubMed
    Score: 0.042
  41. Esophageal function testing using multichannel intraluminal impedance. Am J Physiol Gastrointest Liver Physiol. 2001 Mar; 280(3):G457-62.
    View in: PubMed
    Score: 0.041
  42. Prior sensitization of esophageal mucosa by acid reflux predisposes to reflux-induced chest pain. J Clin Gastroenterol. 2000 Sep; 31(2):121-4.
    View in: PubMed
    Score: 0.040
  43. Acid suppression therapy in Barrett's esophagus: the importance of pH monitoring. Curr Gastroenterol Rep. 2000 Jun; 2(3):173-4.
    View in: PubMed
    Score: 0.039
  44. Importance of adequate acid suppression in the management of Barrett's esophagus. Gastroenterology. 1999 Dec; 117(6):1509-10.
    View in: PubMed
    Score: 0.038
  45. Medical therapy. Management of the refractory patient. Gastroenterol Clin North Am. 1999 Dec; 28(4):847-60.
    View in: PubMed
    Score: 0.038
  46. Oesophageal motility defects associated with nocturnal gastro-oesophageal reflux on proton pump inhibitors. Aliment Pharmacol Ther. 1999 Nov; 13(11):1467-71.
    View in: PubMed
    Score: 0.038
  47. Post-prandial ranitidine is superior to post-prandial omeprazole in control of gastric acidity in healthy volunteers. Aliment Pharmacol Ther. 1999 Sep; 13(9):1211-4.
    View in: PubMed
    Score: 0.037
  48. Ineffective esophageal motility: the most common motility abnormality in patients with GERD-associated respiratory symptoms. Am J Gastroenterol. 1999 Jun; 94(6):1464-7.
    View in: PubMed
    Score: 0.037
  49. Bedtime ranitidine does not eliminate the need for a second daily dose of omeprazole to suppress nocturnal gastric pH. Aliment Pharmacol Ther. 1999 May; 13(5):675-8.
    View in: PubMed
    Score: 0.036
  50. Different effects of an oral anticholinergic drug on gastroesophageal reflux in upright and supine position in normal, ambulant subjects: a pilot study. Am J Gastroenterol. 1999 Apr; 94(4):925-30.
    View in: PubMed
    Score: 0.036
  51. Ranitidine controls nocturnal gastric acid breakthrough on omeprazole: a controlled study in normal subjects. Gastroenterology. 1998 Dec; 115(6):1335-9.
    View in: PubMed
    Score: 0.035
  52. Gastro-oesophageal reflux associated with nocturnal gastric acid breakthrough on proton pump inhibitors. Aliment Pharmacol Ther. 1998 Dec; 12(12):1231-4.
    View in: PubMed
    Score: 0.035
  53. Nocturnal gastric acidity and acid breakthrough on different regimens of omeprazole 40 mg daily. Aliment Pharmacol Ther. 1998 Dec; 12(12):1235-40.
    View in: PubMed
    Score: 0.035
  54. Normal patterns of acid exposure at the gastric cardia: a functional midpoint between the esophagus and stomach. Am J Gastroenterol. 1998 Aug; 93(8):1236-42.
    View in: PubMed
    Score: 0.035
  55. The acid suppression test for unexplained chest pain. Gastroenterology. 1998 Jul; 115(1):222-4.
    View in: PubMed
    Score: 0.034
  56. Globus sensation is associated with hypertensive upper esophageal sphincter but not with gastroesophageal reflux. Dig Dis Sci. 1998 Jul; 43(7):1513-7.
    View in: PubMed
    Score: 0.034
  57. Experimental study of acid burden and acute oesophagitis. Br J Surg. 1998 May; 85(5):677-80.
    View in: PubMed
    Score: 0.034
  58. Effects of omeprazole versus placebo in treatment of noncardiac chest pain and gastroesophageal reflux. Dig Dis Sci. 1997 Oct; 42(10):2138-45.
    View in: PubMed
    Score: 0.033
  59. Ineffective esophageal motility (IEM): the primary finding in patients with nonspecific esophageal motility disorder. Dig Dis Sci. 1997 Sep; 42(9):1859-65.
    View in: PubMed
    Score: 0.033
  60. Evaluation of the antireflux mechanism following laparoscopic fundoplication. Br J Surg. 1997 Aug; 84(8):1157-61.
    View in: PubMed
    Score: 0.032
  61. Accurate measurement of gastric acidity. Am J Gastroenterol. 1997 Jan; 92(1):181.
    View in: PubMed
    Score: 0.031
  62. Prolonged ambulatory pH monitoring in patients with persistent gastroesophageal reflux disease symptoms: testing while on therapy identifies the need for more aggressive anti-reflux therapy. Am J Gastroenterol. 1996 Oct; 91(10):2110-3.
    View in: PubMed
    Score: 0.031
  63. Pulmonary symptoms associated with gastroesophageal reflux: use of ambulatory pH monitoring to diagnose and to direct therapy. Am J Gastroenterol. 1996 Sep; 91(9):1715-8.
    View in: PubMed
    Score: 0.030
  64. Sensitization of esophageal mucosa by prior acid infusion: effect of decreasing intervals between infusions. Am J Gastroenterol. 1996 Sep; 91(9):1745-8.
    View in: PubMed
    Score: 0.030
  65. Persistent acid secretion during omeprazole therapy: a study of gastric acid profiles in patients demonstrating failure of omeprazole therapy. Am J Gastroenterol. 1996 Aug; 91(8):1527-31.
    View in: PubMed
    Score: 0.030
  66. Optimal dosing of omeprazole 40 mg daily: effects on gastric and esophageal pH and serum gastrin in healthy controls. Am J Gastroenterol. 1996 Aug; 91(8):1532-8.
    View in: PubMed
    Score: 0.030
  67. Changes in overnight fasting intragastric pH show poor correlation with duodenogastric bile reflux in normal subjects. Am J Gastroenterol. 1996 Aug; 91(8):1567-70.
    View in: PubMed
    Score: 0.030
  68. Obesity and gastro-oesophageal reflux: is there a relationship? Eur J Gastroenterol Hepatol. 1996 Jul; 8(7):625-6.
    View in: PubMed
    Score: 0.030
  69. Dual site ambulatory pH monitoring: a probe across the lower esophageal sphincter does not induce gastroesophageal reflux. Am J Gastroenterol. 1996 Jun; 91(6):1162-6.
    View in: PubMed
    Score: 0.030
  70. Comparison of barium radiology with esophageal pH monitoring in the diagnosis of gastroesophageal reflux disease. Am J Gastroenterol. 1996 Jun; 91(6):1181-5.
    View in: PubMed
    Score: 0.030
  71. Omeprazole works best when used properly. Eur J Gastroenterol Hepatol. 1996 May; 8(5):413-4.
    View in: PubMed
    Score: 0.030
  72. Omeprazole for the treatment of posterior laryngitis. Am J Med. 1995 Dec; 99(6):694-5.
    View in: PubMed
    Score: 0.029
  73. The effect of nasogastric intubation on gastroesophageal reflux: a comparison of different tube sizes. Am J Gastroenterol. 1995 Oct; 90(10):1804-7.
    View in: PubMed
    Score: 0.028
  74. Hypertensive lower esophageal sphincter pressures and gastroesophageal reflux: an apparent paradox that is not unusual. Am J Gastroenterol. 1995 Feb; 90(2):280-4.
    View in: PubMed
    Score: 0.027
  75. Frequency and site of gastroesophageal reflux in patients with chest symptoms. Studies using proximal and distal pH monitoring. Chest. 1994 Dec; 106(6):1793-6.
    View in: PubMed
    Score: 0.027
  76. Chest pain of undetermined origin. Gastrointest Endosc Clin N Am. 1994 Oct; 4(4):731-46.
    View in: PubMed
    Score: 0.027
  77. Exclusion of meal periods from ambulatory 24-hour pH monitoring may improve diagnosis of esophageal acid reflux. Dig Dis Sci. 1994 Aug; 39(8):1601-7.
    View in: PubMed
    Score: 0.026
  78. Successful elimination of reflux symptoms does not insure adequate control of acid reflux in patients with Barrett's esophagus. Am J Gastroenterol. 1994 Jul; 89(7):989-91.
    View in: PubMed
    Score: 0.026
  79. Pulmonary function and gastroesophageal reflux in systemic sclerosis. Ann Intern Med. 1994 Jul 01; 121(1):6-10.
    View in: PubMed
    Score: 0.026
  80. Body position affects recumbent postprandial reflux. J Clin Gastroenterol. 1994 Jun; 18(4):280-3.
    View in: PubMed
    Score: 0.026
  81. Salivary stimulation mimics esophageal exposure to refluxed duodenal contents. Am J Gastroenterol. 1993 Jul; 88(7):1040-3.
    View in: PubMed
    Score: 0.024
  82. Normal and abnormal proximal esophageal acid exposure: results of ambulatory dual-probe pH monitoring. Am J Gastroenterol. 1993 Jan; 88(1):25-9.
    View in: PubMed
    Score: 0.024
  83. Characterization of patients with low baseline impedance on multichannel intraluminal impedance-pH reflux testing. J Clin Gastroenterol. 2012 Aug; 46(7):e55-7.
    View in: PubMed
    Score: 0.023
  84. Prolonged intraesophageal pH monitoring with 16-hr overnight recording. Comparison with "24-hr" analysis. Dig Dis Sci. 1992 Jun; 37(6):857-64.
    View in: PubMed
    Score: 0.023
  85. Alginic acid decreases postprandial upright gastroesophageal reflux. Comparison with equal-strength antacid. Dig Dis Sci. 1992 Apr; 37(4):589-93.
    View in: PubMed
    Score: 0.022
  86. Impedance pH confirms the relationship between GERD and BMI. Dig Dis Sci. 2012 Jul; 57(7):1875-9.
    View in: PubMed
    Score: 0.022
  87. A simplified technique for accurate placement of ambulatory pH probes. Am J Gastroenterol. 1991 Mar; 86(3):380-1.
    View in: PubMed
    Score: 0.021
  88. Comparison of lower esophageal sphincter manometrics and gastroesophageal reflux measured by 24-hour pH recording. Am J Gastroenterol. 1990 Jun; 85(6):692-6.
    View in: PubMed
    Score: 0.020
  89. Gastroesophageal reflux in runners. Characteristics and treatment. Ann Intern Med. 1990 Mar 15; 112(6):429-33.
    View in: PubMed
    Score: 0.019
  90. Chronic hoarseness secondary to gastroesophageal reflux disease: documentation with 24-h ambulatory pH monitoring. Am J Gastroenterol. 1989 Dec; 84(12):1503-8.
    View in: PubMed
    Score: 0.019
  91. Nonsteroidal antiinflammatory drugs and esophageal injury. Semin Arthritis Rheum. 1989 Oct; 19(2):99-109.
    View in: PubMed
    Score: 0.019
  92. 24 hour ambulatory oesophageal motility monitoring: how should motility data be analysed? Gut. 1989 Aug; 30(8):1040-7.
    View in: PubMed
    Score: 0.019
  93. Asthma and gastroesophageal reflux. Chest. 1989 Jul; 96(1):2-3.
    View in: PubMed
    Score: 0.018
  94. Assessment of accuracy of intraesophageal pH probe in a dog model. Dig Dis Sci. 1989 Jul; 34(7):1079-84.
    View in: PubMed
    Score: 0.018
  95. Gastroesophageal reflux induced by exercise in healthy volunteers. JAMA. 1989 Jun 23-30; 261(24):3599-601.
    View in: PubMed
    Score: 0.018
  96. Does the intraesophageal pH probe accurately detect acid reflux? Simultaneous recording with two pH probes in humans. Dig Dis Sci. 1989 May; 34(5):649-56.
    View in: PubMed
    Score: 0.018
  97. Chocolate and heartburn: evidence of increased esophageal acid exposure after chocolate ingestion. Am J Gastroenterol. 1988 Jun; 83(6):633-6.
    View in: PubMed
    Score: 0.017
  98. The symptom index: a clinically important parameter of ambulatory 24-hour esophageal pH monitoring. Am J Gastroenterol. 1988 Apr; 83(4):358-61.
    View in: PubMed
    Score: 0.017
  99. Review article: acidity and volume of the refluxate in the genesis of gastro-oesophageal reflux disease symptoms. Aliment Pharmacol Ther. 2007 May 01; 25(9):1003-17.
    View in: PubMed
    Score: 0.016
  100. Histamine H2-receptor involvement in the regulation of gastric emptying. Am J Physiol. 1986 Feb; 250(2 Pt 1):G244-7.
    View in: PubMed
    Score: 0.015
  101. Ambulatory 24-hour esophageal pH monitoring. Technology searching for a clinical application. J Clin Gastroenterol. 1986; 8 Suppl 1:59-67.
    View in: PubMed
    Score: 0.014
  102. Respiratory complications of gastroesophageal reflux. Arch Intern Med. 1985 Oct; 145(10):1882-8.
    View in: PubMed
    Score: 0.014
  103. Reflux esophagitis: an update. South Med J. 1985 Apr; 78(4):452-7.
    View in: PubMed
    Score: 0.014
  104. Clinical applications of oesophageal motility studies? Br J Hosp Med. 1984 Nov; 32(5):267-71.
    View in: PubMed
    Score: 0.013
  105. Gastro-oesophageal reflux monitoring: review and consensus report on detection and definitions of acid, non-acid, and gas reflux. Gut. 2004 Jul; 53(7):1024-31.
    View in: PubMed
    Score: 0.013
  106. The acidity index: a simple approach to the measurement of gastric acidity. Aliment Pharmacol Ther. 2004 Feb 15; 19(4):443-8.
    View in: PubMed
    Score: 0.013
  107. Laryngopharyngeal reflux identified using a new catheter design: defining normal values and excluding artifacts. Laryngoscope. 2003 Feb; 113(2):349-55.
    View in: PubMed
    Score: 0.012
  108. Gastroesophageal reflux. Pathogenesis, diagnosis, and therapy. Ann Intern Med. 1982 Jul; 97(1):93-103.
    View in: PubMed
    Score: 0.011
  109. In support of the clinical usefulness of lower esophageal sphincter pressure determination. Dig Dis Sci. 1981 Nov; 26(11):1028-31.
    View in: PubMed
    Score: 0.011
  110. Radiofrequency energy delivery to the gastroesophageal junction for the treatment of GERD. Gastrointest Endosc. 2001 Apr; 53(4):407-15.
    View in: PubMed
    Score: 0.010
  111. The adverse effect of chocolate on lower esophageal sphincter pressure. Am J Dig Dis. 1975 Aug; 20(8):703-7.
    View in: PubMed
    Score: 0.007
  112. Gastric alkalinization. Effect on lower-esophageal-sphincter pressure and serum gastrin. N Engl J Med. 1974 Sep 05; 291(10):486-90.
    View in: PubMed
    Score: 0.007
  113. Comparative studies on human plasma monoamine oxidase in normal subjects and in fibrotic liver disease. Biochem Med. 1974 Apr; 9(4):373-85.
    View in: PubMed
    Score: 0.006
  114. The abnormal lower oesophageal sphincter in pernicious anaemia. Gut. 1973 Oct; 14(10):767-72.
    View in: PubMed
    Score: 0.006
  115. Esophageal function in systemic sclerosis: a prospective evaluation of motility and acid reflux in 36 patients. Am J Gastroenterol. 1993 Jun; 88(6):870-6.
    View in: PubMed
    Score: 0.006
  116. Cholinergic response of the lower esophageal sphincter. Am J Physiol. 1972 Apr; 222(4):967-72.
    View in: PubMed
    Score: 0.006
  117. Changes in lower esophageal sphincter pressure during insulin-induced hypoglycemia. Gastroenterology. 1971 Jul; 61(1):10-5.
    View in: PubMed
    Score: 0.005
  118. Dysphagia following fundoplication: "slipped" fundoplication versus achalasia complicated by fundoplication. Am J Gastroenterol. 1990 Nov; 85(11):1468-72.
    View in: PubMed
    Score: 0.005
  119. Response of human ileocecal sphincter to gastrin. Am J Physiol. 1970 Sep; 219(3):712-5.
    View in: PubMed
    Score: 0.005
  120. Hormonal control of gastroesophageal-sphincter strength. N Engl J Med. 1970 Apr 16; 282(16):886-9.
    View in: PubMed
    Score: 0.005
  121. Does sleeping on a waterbed promote gastroesophageal reflux? Dig Dis Sci. 1989 Oct; 34(10):1585-9.
    View in: PubMed
    Score: 0.005
  122. Acid perfusion test: does it have a role in the assessment of non cardiac chest pain? Gut. 1989 Mar; 30(3):305-10.
    View in: PubMed
    Score: 0.005
  123. Ambulatory 24-hour esophageal pH monitoring. Reproducibility and variability of pH parameters. Dig Dis Sci. 1988 Sep; 33(9):1127-33.
    View in: PubMed
    Score: 0.004
  124. Spontaneous noncardiac chest pain. Evaluation by 24-hour ambulatory esophageal motility and pH monitoring. Gastroenterology. 1988 Apr; 94(4):878-86.
    View in: PubMed
    Score: 0.004
  125. Effect of a prostaglandin E2 analog on gastric emptying and secretion in rhesus monkeys. J Pharmacol Exp Ther. 1980 Mar; 212(3):491-5.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.